Pediatric Bone Marrow Transplant for Leukemia (ALL, AML, CML) at Sheba Hospital- JCI accreditated and Top-10 Hospitals 2025 by Newsweek
このパッケージに含まれるもの
医療処置
- 全血球計算検査
- 生化学的血液検査
- 血液内科相談
- 血液検査
- 骨髄生検
- オンコヘマトロジー相談
- 白血病の包括的検査
- 骨髄細胞遺伝学的検査
- 骨髄移植術
- 栄養士による1日3食
- 24時間看護サービス
- 心電図(ECG)
- 血液検査
- 胸部X線
- HIV抗体検査
- B型肝炎コア抗体検査
- 抗HCV抗体検査
- 心エコー図検査
- 全血球計算(CBC)
- 生化学血液検査
- PET/CT
- 免疫専門医への相談
- 循環器科医への相談
- 小児血液専門医との相談
- 小児科医との相談
- 腫瘍血液専門医との診察
- 頭部MRI
- 生検
- 腫瘍マーカーおよび蛋白分画を含む全血球算定
期間
- 30 日 病院で
宿泊
入院
交通
空港-クリニック-空港間の送迎
追加情報
Pediatric Bone Marrow Transplant for Leukemia (ALL, AML, CML)
Sheba Medical Center – Personalized, Advanced Care for Children
At Sheba Medical Center, we understand that a diagnosis of leukemia in a child changes everything for a family. Our Pediatric Bone Marrow Transplant (BMT) program is designed to provide not only world-class medical care, but also reassurance, compassion, and hope at every step.
As one of the leading pediatric transplant centers globally, Sheba combines decades of experience with cutting-edge therapies to treat children with acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and chronic myeloid leukemia (CML) especially in high-risk or relapsed cases where transplant offers the best chance for cure.
When is a Bone Marrow Transplant Needed?
For many children, leukemia can be successfully treated with chemotherapy. However, in certain situations such as relapse, resistance to treatment, or high-risk disease, a bone marrow transplant becomes the most effective path forward.
A transplant replaces the child’s diseased bone marrow with healthy stem cells, allowing a new, functioning immune system to develop and fight the cancer.
A Personalized Approach to Every Child
No two children are the same and neither are their treatments. At Sheba, every case is carefully evaluated by a multidisciplinary team of pediatric hemato-oncology and transplant experts to determine the optimal timing, donor source, and treatment strategy.
Whenever possible, a matched sibling donor is preferred.
If a sibling match is not available, Sheba actively secures the best possible alternative donor through advanced matching technologies and international registries. These include:
Matched unrelated donors from global donor programs
Haploidentical (partial match) family donors, such as parents
Cord blood transplants
Our advanced HLA and molecular laboratories enable precise donor matching, ensuring both safety and the highest likelihood of success.
Advanced Transplant Techniques
Sheba is recognized for applying the most advanced transplant methods available today, including:
T-cell depletion and CD34+ selection to reduce complications and improve outcomes
Integration of CAR-T cell therapy prior to transplant in selected high-risk leukemia cases
Access to innovative clinical trials and emerging therapies
These technologies allow us to safely perform transplants even in complex or previously untreatable situations.
World-Class Outcomes
Sheba’s Pediatric BMT program consistently achieves outcomes that meet or exceed international standards:
ALL & AML (first or second remission): ~70–85% success rates
Improved outcomes in relapsed cases through integration of advanced cellular therapies
Strong long-term survival and quality of life for pediatric patients
Our experience, combined with continuous research and innovation, allows us to offer children the best possible chance for cure.
Care Beyond Treatment
A bone marrow transplant is not just a procedure, it is a journey. At Sheba, children are cared for in dedicated, highly protected environments with advanced infection control, while families receive continuous guidance, emotional support, and clear communication throughout the process.
From diagnosis through recovery and long-term follow-up, our team remains closely involved—ensuring that each child not only overcomes the disease, but also returns to a healthy and fulfilling life.
Why Families Choose Sheba
Leading pediatric transplant center with global recognition
Expertise in complex and high-risk leukemia cases
Ability to secure suitable donors—even without a family match
Integration of CAR-T and advanced cellular therapies
Multidisciplinary, patient-centered care
Dedicated international patient services for a smooth experience
A Message of Hope
At Sheba Medical Center, we believe every child deserves access to the most advanced treatments available—delivered with compassion, precision, and unwavering commitment.
For children facing leukemia, bone marrow transplantation at Sheba is not just a treatment option—it is a pathway toward healing, recovery, and a brighter future.
24時間年中無休Bookimedサポート
- 専任医療コーディネーター
- 医療旅行手配 — 特別パートナー価格での航空券・ホテル予約
- 医療旅行中の患者擁護
プログラム料金
このパッケージに含まれないもの
医師
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.
調子はいかがですか?
クリニックについて
シェバ医療センターはイスラエルおよび世界有数の病院の一つです。 ニューズウィーク・インターナショナル誌は、Sheba Hospitalを2020年の世界トップ10病院にランク付けしました。同病院は1,990の専門分野をカバーしており、毎年世界中から1,500,000人を超える患者がシェバ病院を受診しています。
支払い・特典
当社サービスへのお支払いはありません
クリニックで直接またはその公式銀行口座にお支払いいただきます。
一部のクリニックでは保証金が必要な場合があります。
分割払いオプションでお支払いを分散してください。
Bookimedにお友達を紹介して報酬を獲得してください。